Literature DB >> 17237433

Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization.

Anna Di Nardo1, Marissa H Braff, Kristen R Taylor, Changrim Na, Richard D Granstein, Jamie E McInturff, Stephan Krutzik, Robert L Modlin, Richard L Gallo.   

Abstract

Cathelicidins are antimicrobial peptides of the innate immune system that establish an antimicrobial barrier at epithelial interfaces and have been proposed to have a proinflammatory function. We studied the role of cathelicidin in allergic contact dermatitis, a model requiring dendritic cells of the innate immune response and T cells of the adaptive immune response. Deletion of the murine cathelicidin gene Cnlp enhanced an allergic contact response, whereas local administration of cathelicidin before sensitization inhibited the allergic response. Cathelicidins inhibited TLR4 but not TLR2 mediated induction of dendritic cell maturation and cytokine release, and this inhibition was associated with an alteration of cell membrane function and structure. Further analysis in vivo connected these observations because inhibition of sensitization by exogenous cathelicidin was dependent on the presence of functional TLR4. These observations provide evidence that cathelicidin antimicrobial peptides mediate an anti-inflammatory response in part by their activity at the membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237433     DOI: 10.4049/jimmunol.178.3.1829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression.

Authors:  Attila S Antal; Yvonne Dombrowski; Sarah Koglin; Thomas Ruzicka; Jürgen Schauber
Journal:  Dermatoendocrinol       Date:  2011-01

2.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 3.  Epithelial antimicrobial defence of the skin and intestine.

Authors:  Richard L Gallo; Lora V Hooper
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

4.  Sounding the alarm: multiple functions of host defense peptides.

Authors:  Richard L Gallo
Journal:  J Invest Dermatol       Date:  2008-01       Impact factor: 8.551

5.  Innate barriers against infection and associated disorders.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Drug Discov Today Dis Mech       Date:  2008-06-01

6.  IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.

Authors:  Mark Peric; Sarah Koglin; Song-Min Kim; Shin Morizane; Robert Besch; Jörg C Prinz; Thomas Ruzicka; Richard L Gallo; Jürgen Schauber
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 7.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

Review 8.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

Review 9.  Antimicrobial peptides and the skin immune defense system.

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  J Allergy Clin Immunol       Date:  2008-04-25       Impact factor: 10.793

10.  Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.

Authors:  Patrick A M Jansen; Diana Rodijk-Olthuis; Edward J Hollox; Marijke Kamsteeg; Geuranne S Tjabringa; Gys J de Jongh; Ivonne M J J van Vlijmen-Willems; Judith G M Bergboer; Michelle M van Rossum; Elke M G J de Jong; Martin den Heijer; Andrea W M Evers; Mieke Bergers; John A L Armour; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.